Skip to content

    Elevance Health, Inc.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $45.11B
    $45.44B
    $48.89B
    $49.78B
    $50.71B
    +12.4%
    $49.75B
    +9.5%
    $50.18B
    +2.6%
    $50.47B
    +1.4%
    Strengthening
    Operating Profit
    $1.41B
    $673.00M
    $3.17B
    $2.42B
    $1.29B
    -8.0%
    $309.00M
    -54.1%
    $2.09B
    -34.2%
    $1.76B
    -27.3%
    Weakening
    Net Profit
    $1.02B
    $418.00M
    $2.18B
    $1.74B
    $1.19B
    +17.0%
    $547.00M
    +30.9%
    $1.76B
    -19.2%
    $1.46B
    -16.1%
    Stable
    EPS
    $4.38
    $9.64
    $7.74
    $5.32
    +21.5%
    $8.03
    -16.7%
    $6.74
    -12.9%
    Weakening
    Other Income
    Interest
    $300.00M
    $340.00M
    $344.00M
    $341.00M
    $351.00M
    +17.0%
    $366.00M
    +7.6%
    $357.00M
    +3.8%
    $364.00M
    +6.7%
    Strengthening
    Depreciation
    Profit before Tax
    $1.37B
    $606.00M
    $2.80B
    $2.29B
    $1.41B
    +2.4%
    $215.00M
    -64.5%
    $2.30B
    -17.6%
    $1.94B
    -15.5%
    Weakening
    MarginsOPM
    3.1%
    1.5%
    6.5%
    4.9%
    2.5%
    -18.3%
    0.6%
    -58.1%
    4.2%
    -35.8%
    3.5%
    -28.3%
    Weakening
    Tax
    26.6%
    31.9%
    21.9%
    23.9%
    15.6%
    -41.4%
    -153.9%
    -583.4%
    23.6%
    +7.7%
    24.9%
    +4.3%
    Weakening
    ReturnsROIC
    2.8%
    1.1%
    6.0%
    4.8%
    3.2%
    +17.0%
    1.5%
    +30.9%
    4.8%
    -19.2%
    4.0%
    -16.1%
    Stable

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$3.93B$4.94B$5.74B$4.88B$7.39B$6.53B$8.29B$9.49B$10.23B
    Short-Term Investments
    Total Current Assets$34.32B$39.03B$45.75B$51.12B$55.62B$60.03B$58.94B$63.00B$67.18B
    Net PP&E$2.73B$3.13B$3.48B$4.55B$4.92B$4.94B$5.22B$5.13B$4.64B
    Goodwill$20.50B$20.50B$21.69B$24.23B$24.38B$25.32B$28.28B$28.34B$28.34B
    Intangibles$9.01B$8.67B$9.40B$10.62B$10.31B$10.27B$12.09B$11.20B$10.98B
    Total Assets$71.57B$77.45B$86.61B$97.46B$102.75B$108.93B$116.89B$121.49B$126.44B
    LiabilitiesTotal Current Liabilities$21.96B$23.53B$29.45B$34.88B$39.70B$41.79B$40.58B$41.03B$44.25B
    Short-Term Debt$849.00M$1.60B$700.00M$1.60B$1.50B$1.65B$1.65B$1.10B$375.00M
    Long-Term Debt$17.22B$17.79B$19.34B$21.16B$22.35B$23.25B$29.22B$30.80B$30.67B
    Long-Term Leases$864.00M$751.00M$685.00M$658.00M$529.00M
    Total Liabilities$43.03B$45.73B$53.42B$61.29B$66.42B$69.52B$75.46B$77.47B$81.42B
    EquityCommon Stock & APIC$3.00M$3.00M$3.00M$2.00M$2.00M$2.00M$2.00M$2.00M$2.00M
    Retained Earnings$19.99B$22.57B$23.80B$27.14B$29.65B$31.75B$33.55B$35.39B$36.67B
    Total Equity$28.54B$31.73B$33.20B$36.09B$36.24B$39.31B$41.31B$43.88B$44.88B
    HighlightsNet Cash / (Debt)-$14.13B-$14.45B-$14.29B-$17.88B-$16.46B-$18.37B-$22.58B-$22.41B-$20.81B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$3.83B$6.06B$10.69B$8.36B$8.40B$8.06B$5.81B$4.29B$7.46B
    Cash from Investing-$1.26B-$2.79B-$7.32B-$9.64B-$4.56B-$5.57B-$5.17B-$1.34B-$2.24B
    Cash from Financing-$2.24B-$2.27B-$2.57B$423.00M-$1.32B-$3.35B$1.19B-$1.74B-$3.53B
    SummaryCapital Expenditure-$1.21B-$1.08B-$1.02B-$1.09B-$1.15B-$1.30B-$1.26B-$1.12B-$1.18B
    Free Cash Flow$2.62B$4.98B$9.67B$7.28B$7.25B$6.76B$4.55B$3.17B$6.29B
    FCF Margin2.8%4.8%5.2%4.6%3.9%2.6%1.6%3.1%